303 related articles for article (PubMed ID: 27865961)
1. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Whitworth SR; Bruce DG; Starkstein SE; Davis WA; Davis TM; Bucks RS
Diabetes Res Clin Pract; 2016 Dec; 122():190-197. PubMed ID: 27865961
[TBL] [Abstract][Full Text] [Related]
2. The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.
Davis WA; Bruce DG; Dragovic M; Davis TME; Starkstein SE
PLoS One; 2018; 13(3):e0194417. PubMed ID: 29543862
[TBL] [Abstract][Full Text] [Related]
3. Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5-year depression trajectories using latent class growth analysis.
Whitworth SR; Bruce DG; Starkstein SE; Davis WA; Davis TME; Skinner TC; Bucks RS
Diabet Med; 2017 Aug; 34(8):1108-1115. PubMed ID: 28453875
[TBL] [Abstract][Full Text] [Related]
4. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey--Mental Health (CCHS-MH).
Deschênes SS; Burns RJ; Schmitz N
J Psychosom Res; 2015 Feb; 78(2):137-42. PubMed ID: 25510185
[TBL] [Abstract][Full Text] [Related]
5. Does Social Support Moderate the Association Among Major Depression, Generalized Anxiety Disorder, and Functional Disability in Adults With Diabetes?
Levy M; Burns RJ; Deschênes SS; Schmitz N
Psychosomatics; 2017; 58(4):364-374. PubMed ID: 28413087
[TBL] [Abstract][Full Text] [Related]
6. Lifetime depression history and depression risk in type 2 diabetes: A case-control study.
Bruce DG; Davis WA; Hunter ML; Peters KE; Davis TM; Starkstein SE
J Diabetes Complications; 2016; 30(1):38-42. PubMed ID: 26604164
[TBL] [Abstract][Full Text] [Related]
7. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
[TBL] [Abstract][Full Text] [Related]
8. Anxiety and depression symptoms in patients with diabetes.
Collins MM; Corcoran P; Perry IJ
Diabet Med; 2009 Feb; 26(2):153-61. PubMed ID: 19236618
[TBL] [Abstract][Full Text] [Related]
9. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting.
Lamb RC; Matcham F; Turner MA; Rayner L; Simpson A; Hotopf M; Barker JNWN; Jackson K; Smith CH
Br J Dermatol; 2017 Apr; 176(4):1028-1034. PubMed ID: 27363600
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.
Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474
[TBL] [Abstract][Full Text] [Related]
11. Depression, anxiety, and nonalcoholic steatohepatitis.
Elwing JE; Lustman PJ; Wang HL; Clouse RE
Psychosom Med; 2006; 68(4):563-9. PubMed ID: 16868265
[TBL] [Abstract][Full Text] [Related]
12. Depression but not anxiety is associated with metabolic syndrome in primary care based community sample.
Butnoriene J; Bunevicius A; Norkus A; Bunevicius R
Psychoneuroendocrinology; 2014 Feb; 40():269-76. PubMed ID: 24485498
[TBL] [Abstract][Full Text] [Related]
13. Depression, anxiety, and prevalent diabetes in the Chinese population: findings from the China Kadoorie Biobank of 0.5 million people.
Mezuk B; Chen Y; Yu C; Guo Y; Bian Z; Collins R; Chen J; Pang Z; Wang H; Peto R; Que X; Zhang H; Tan Z; Kendler KS; Li L; Chen Z
J Psychosom Res; 2013 Dec; 75(6):511-7. PubMed ID: 24290039
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study Phase II.
Davis TM; Hunt K; Bruce DG; Starkstein S; Skinner T; McAullay D; Davis WA
Diabetes Res Clin Pract; 2015 Mar; 107(3):384-91. PubMed ID: 25656760
[TBL] [Abstract][Full Text] [Related]
15. Psychological distress, self-efficacy and glycemic control in type 2 diabetes.
Indelicato L; Dauriz M; Santi L; Bonora F; Negri C; Cacciatori V; Targher G; Trento M; Bonora E
Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):300-306. PubMed ID: 28274728
[TBL] [Abstract][Full Text] [Related]
16. Comorbid Anxiety and Depression and Their Impact on Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.
Bruce DG; Davis WA; Dragovic M; Davis TM; Starkstein SE
Depress Anxiety; 2016 Oct; 33(10):960-966. PubMed ID: 27164424
[TBL] [Abstract][Full Text] [Related]
17. The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults With Type 2 Diabetes Mellitus.
Golden SH; Shah N; Naqibuddin M; Payne JL; Hill-Briggs F; Wand GS; Wang NY; Langan S; Lyketsos C
Psychosomatics; 2017; 58(1):28-37. PubMed ID: 27692654
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study.
Cyranowski JM; Schott LL; Kravitz HM; Brown C; Thurston RC; Joffe H; Matthews KA; Bromberger JT
Depress Anxiety; 2012 Dec; 29(12):1050-7. PubMed ID: 22930404
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.
Starkstein SE; Davis WA; Dragovic M; Cetrullo V; Davis TM; Bruce DG
PLoS One; 2014; 9(11):e112049. PubMed ID: 25390370
[TBL] [Abstract][Full Text] [Related]
20. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder.
Lenze EJ; Mulsant BH; Mohlman J; Shear MK; Dew MA; Schulz R; Miller MD; Tracey B; Reynolds CF
Am J Geriatr Psychiatry; 2005 Jan; 13(1):77-80. PubMed ID: 15653943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
